Organization and Description of Business Operations - Additional Information (Details) - USD ($)					1 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 26, 2022	Oct. 21, 2022	Oct. 05, 2021	Oct. 31, 2022	Apr. 30, 2022	Sep. 30, 2022	Dec. 31, 2021
Organization and Description of Business Operations [Line Items]
Date of incorporation							Feb. 13, 2020
Net proceeds from issuance of common stock							$ 11,640,000
Common stock, shares issued							41,175,939	38,473,945
Common stock, par value per share							$ 0.00001	$ 0.00001
Astellas
Organization and Description of Business Operations [Line Items]
Upfront payment			$ 20,000,000.0		$ 20,000,000.0
Gross proceeds including upfront payments					50,000,000.0
Sales Agreement
Organization and Description of Business Operations [Line Items]
Common stock shares issued and sold							0
Number of shares issued						2,000,000
Net proceeds from issuance of common stock						$ 11,600,000
Sales Agreement | Sales Agents
Organization and Description of Business Operations [Line Items]
Percentage of gross sales price per share of common stock				3.00%
Sales Agreement | Sales Agents | Maximum
Organization and Description of Business Operations [Line Items]
Aggregate offering price from sale of common stock				$ 150,000,000.0
Securities Purchase Agreement | Private Placement [Member] | Astellas
Organization and Description of Business Operations [Line Items]
Net proceeds from issuance of common stock					$ 30,000,000.0
Common stock, shares issued	7,266,342		7,266,342		7,266,342
Underwriting Agreement
Organization and Description of Business Operations [Line Items]
Net proceeds from issuance of common stock	$ 25,600,000				$ 25,600,000
Common stock, shares issued	14,000,000	14,000,000			14,000,000
Common stock, par value per share	$ 2.00	$ 2.00			$ 2.00
Underwriter period for option to purchase additional share		30 days			30 days
Option to purchase additional number of shares	2,100,000	2,100,000			2,100,000
Underwriter agreed to purchase share price of per share	$ 1.88	$ 1.88			$ 1.88
Estimated net proceeds from offering if underwriter exercises options	$ 29,600,000				$ 29,600,000